This study provided a new insight into the interaction between osteosarcoma cells and macrophages in the tumor microenvironment, and highlight the potential of LIFR-AS1/miR-29a/NFIA as novel therapeutic targets for osteosarcoma therapy. This evidence concerns the gene LIFR and osteosarcoma.